1

Depyrogenated Sterile Empty Vials Market (By Capacity: 2 ml, 5 ml, 10 ml, 20 ml, More than 20 ml; By Material: Glass, Plastic; By End-Use: Compounding Labs, Clinical Labs, Pharmaceutical Manufacturers, Others) – Global Industry Analysis, Market Size, Opportunities and Forecast, 2019 - 2026

Category : Healthcare and Pharmaceuticals | Delivery Format: PDF | Status: Published | Pages : 190

Table Of Content:

CHAPTER 1. INDUSTRY OVERVIEW
1.1. Definition and Scope
   1.1.1. Definition of Depyrogenated Sterile Empty Vials
   1.1.2. Market Segmentation
   1.1.3. List of Abbreviations
1.2. Summary
   1.2.1. Market Snapshot
   1.2.2. Depyrogenated Sterile Empty Vials Market By Capacity
     1.2.2.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By Capacity (2015-2026)
     1.2.2.2. Global Depyrogenated Sterile Empty Vials Market Revenue Share By Capacity in 2018
     1.2.2.3. 2 ml
     1.2.2.4. 5 ml
     1.2.2.5. 10 ml
     1.2.2.6. 20 ml
     1.2.2.7. More than 20 ml
   1.2.3. Depyrogenated Sterile Empty Vials Market By Material
     1.2.3.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By Material (2015-2026)
     1.2.3.2. Glass
     1.2.3.3. Plastic
   1.2.4. Depyrogenated Sterile Empty Vials Market By End-user
     1.2.4.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By End-user (2015-2026)
     1.2.4.2. Compounding Labs
     1.2.4.3. Clinical Labs
     1.2.4.4. Pharmaceutical Manufacturers
     1.2.4.5. Others (Contract manufacturing organizations, Distributors)
   1.2.5. Depyrogenated Sterile Empty Vials Market By Geography
     1.2.5.1. Global Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate Comparison By Geography (2015-2026)
     1.2.5.2. North America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
     1.2.5.3. Europe Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
     1.2.5.4. Asia-Pacific Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
     1.2.5.5. Latin America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)
     1.2.5.6. Middle East and Africa (MEA) Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate(2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS
2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porter’s Five Forces Analysis
   2.4.1. Bargaining Power of Suppliers
   2.4.2. Bargaining Power of Buyers
   2.4.3. Threat of Substitute
   2.4.4. Threat of New Entrants
   2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
   2.6.1. Raw Material and Suppliers
   2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2018
   2.8.1. Player Positioning Analysis
   2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS
3.1. Capacity and Commercial Production Date of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
3.2. Manufacturing Plants Distribution of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
3.3. R&D Status and Technology Source of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018
3.4. Raw Materials Sources Analysis of Global Depyrogenated Sterile Empty Vials Major Manufacturers in 2018

CHAPTER 4. DEPYROGENATED STERILE EMPTY VIALS MARKET BY CAPACITY
4.1. Global Depyrogenated Sterile Empty Vials Revenue By Capacity
4.2. 2 ml
   4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. 5 ml
   4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. 10 ml
   4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. 20 ml
   4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.6. More than 20 ml
   4.6.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   4.6.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. DEPYROGENATED STERILE EMPTY VIALS MARKET BY MATERIAL
5.1. Global Depyrogenated Sterile Empty Vials Revenue By Material
5.2. Glass
   5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Plastic
   5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. DEPYROGENATED STERILE EMPTY VIALS MARKET BY END-USER
6.1. Global Depyrogenated Sterile Empty Vials Revenue By End-user
6.2. Compounding Labs
   6.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.3. Clinical Lab
   6.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.4. Pharmaceutical Manufacturers
   6.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
6.5. Others (Contract manufacturing organizations, Distributors)
   6.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
   6.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 7. NORTH AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
7.1. North America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. North America Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
7.3. U.S.
   7.3.1. U.S. Depyrogenated Sterile Empty Vials Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   7.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   7.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
7.4. Canada
   7.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   7.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   7.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 8. EUROPE DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
8.1. Europe Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Europe Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
8.3. UK
   8.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   8.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   8.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.4. Germany
   8.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   8.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   8.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.5. France
   8.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   8.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   8.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.6. Spain
   8.6.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   8.6.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   8.6.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
8.7. Rest of Europe
   8.7.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   8.7.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   8.7.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 9. ASIA-PACIFIC DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
9.1. Asia-Pacific Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Asia-Pacific Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
9.3. China
   9.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   9.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   9.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.4. Japan
   9.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   9.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   9.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.5. India
   9.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   9.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   9.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.6. Australia
   9.6.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   9.6.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   9.6.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.7. South Korea
   9.7.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   9.7.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   9.7.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
9.8. Rest of Asia-Pacific
   9.8.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   9.8.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   9.8.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 10. LATIN AMERICA DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
10.1. Latin America Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Latin America Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
10.3. Brazil
   10.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   10.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   10.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.4. Mexico
   10.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   10.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   10.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
10.5. Rest of Latin America
   10.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   10.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   10.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 11. MIDDLE EAST & AFRICA DEPYROGENATED STERILE EMPTY VIALS MARKET BY COUNTRY
11.1. Middle East & Africa Depyrogenated Sterile Empty Vials Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Middle East & Africa Depyrogenated Sterile Empty Vials Market Revenue Share Comparison, 2015 & 2026 (%)
11.3. GCC
   11.3.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   11.3.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   11.3.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.4. South Africa
   11.4.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   11.4.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   11.4.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)
11.5. Rest of Middle East & Africa
   11.5.1. Market Revenue and Forecast By Capacity, 2015 - 2026 ($Million)
   11.5.2. Market Revenue and Forecast By Material, 2015 - 2026 ($Million)
   11.5.3. Market Revenue and Forecast By End-user, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE
12.1. Corning Incorporated
   12.1.1. Company Snapshot
   12.1.2. Overview
   12.1.3. Financial Overview
   12.1.4. Type Portfolio
   12.1.5. Key Developments
   12.1.6. Strategies
12.2. Thermo Fisher Scientific
   12.2.1. Company Snapshot
   12.2.2. Overview
   12.2.3. Financial Overview
   12.2.4. Type Portfolio
   12.2.5. Key Developments
   12.2.6. Strategies
12.3. APG Pharma
   12.3.1. Company Snapshot
   12.3.2. Overview
   12.3.3. Financial Overview
   12.3.4. Type Portfolio
   12.3.5. Key Developments
   12.3.6. Strategies
12.4. DWK Life Sciences
   12.4.1. Company Snapshot
   12.4.2. Overview
   12.4.3. Financial Overview
   12.4.4. Type Portfolio
   12.4.5. Key Developments
   12.4.6. Strategies
12.5. VWR International
   12.5.1. Company Snapshot
   12.5.2. Overview
   12.5.3. Financial Overview
   12.5.4. Type Portfolio
   12.5.5. Key Developments
   12.5.6. Strategies
12.6. Nipro PharmaPackaging
   12.6.1. Company Snapshot
   12.6.2. Overview
   12.6.3. Financial Overview
   12.6.4. Type Portfolio
   12.6.5. Key Developments
   12.6.6. Strategies
12.7. Gerresheimer
   12.7.1. Company Snapshot
   12.7.2. Overview
   12.7.3. Financial Overview
   12.7.4. Type Portfolio
   12.7.5. Key Developments
   12.7.6. Strategies
12.8. Merck KGaA
   12.8.1. Company Snapshot
   12.8.2. Overview
   12.8.3. Financial Overview
   12.8.4. Type Portfolio
   12.8.5. Key Developments
   12.8.6. Strategies
12.9. Radpharm Scientific
   12.9.1. Company Snapshot
   12.9.2. Overview
   12.9.3. Financial Overview
   12.9.4. Type Portfolio
   12.9.5. Key Developments
   12.9.6. Strategies
12.10. Stevanato Group
   12.10.1. Company Snapshot
   12.10.2. Overview
   12.10.3. Financial Overview
   12.10.4. Type Portfolio
   12.10.5. Key Developments
   12.10.6. Strategies
12.11. SCHOTT
   12.11.1. Company Snapshot
   12.11.2. Overview
   12.11.3. Financial Overview
   12.11.4. Type Portfolio
   12.11.5. Key Developments
   12.11.6. Strategies
12.12. Others
   12.12.1. Company Snapshot
   12.12.2. Overview
   12.12.3. Financial Overview
   12.12.4. Type Portfolio
   12.12.5. Key Developments
   12.12.6. Strategies

CHAPTER 13. RESEARCH APPROACH
13.1. Research Methodology
   13.1.1. Initial Data Search
   13.1.2. Secondary Research
   13.1.3. Primary Research
13.2. Assumptions and Scope

Cart Summary